Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Frozen Plasma Transfusion Practices in Ontario-an Electronic Audit at Five Tertiary Care Hospitals to Inform a Knowledge Translation Strategy to Reduce Inappropriate Plasma Transfusions

Leigh Minuk, MD, Jeannie Callum, MD

Blood (2018) 132 (Supplement 1): 5083.

https://doi.org/10.1182/blood-2018-99-119859

Published: 2018

Journal Articles

A Single-Institution Retrospective Study of Causes of Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the Outpatient Setting

Ryan B. Khodadadi, MD, Joshua P. Slusser, B.S., Diane E. Grill, M.S., Rajiv K. Pruthi, M.B.B.S., Ariela L. Marshall, MD

Blood (2018) 132 (Supplement 1): 2281.

https://doi.org/10.1182/blood-2018-99-109833

Published: 2018

Journal Articles

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Prolonged Isolated Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By N-Acetyl-L-Cysteine

Yuan Kong, Minmin Shi, Yuanyuan Zhang, Xie-Na Cao, Qi Wen, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Xiaojun Huang

Blood (2017) 130 (Supplement 1): 2300.

https://doi.org/10.1182/blood.V130.Suppl_1.2300.2300

Published: 2017

Journal Articles

Prolonged Prothrombin Time in DIC: Contributions of Excess Thrombin and Fibrinogen Degradation Products

Michael Meledeo, PhD, Prajeeda M Nair, PhD, Grantham Peltier, MS, Ashley S Taylor, BA, James Bynum, PhD, Andrew P. Cap, MD PhD

Blood (2017) 130 (Supplement 1): 2346.

https://doi.org/10.1182/blood.V130.Suppl_1.2346.2346

Published: 2017

Journal Articles

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Andres Forero-Torres, MD, Seth Rosen, MD, David C. Smith, MD, Glenn Lesser, MD, Julio Peguero, MD, Shilpa Gupta, MD, Justin M. Watts, MD, Marcus Noel, MD, Razelle Kurzrock, MD, Haeseong Park, MD, Patricia LoRusso, DO, Catherine C. Coombs, MD, Fred Zheng, MD, Julie Switzky, RN, Swamy Yeleswaram, PhD, Gerald Falchook, MD

Blood (2017) 130 (Supplement 1): 4048.

https://doi.org/10.1182/blood.V130.Suppl_1.4048.4048

Published: 2017

Journal Articles

Identification and Characterization of a New Mutation in Coagulation Factor VII (Carmel mutation), with Different Reactivity Towards Tissue Factors of Different Origin

Aliza Cassel, PhD, Nurit Rosenberg, PhD, Emad Muhammad, PhD, Rima Dazdik, PhD, Miriam Berl, Meir Preis, MD PhD

Blood (2016) 128 (22): 1396.

https://doi.org/10.1182/blood.V128.22.1396.1396

Published: 2016

Journal Articles

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

Eriko Morishita, MD PhD, Mao Takata, BSc, Fumina Taniguchi, BSc, Masashi Akiyama, PhD, Akiko Sekiya, PhD, Akira Takagi, PhD, Toshiyuki Miyata, PhD, Tetsuhito Kojima, MD PhD

Blood (2016) 128 (22): 2574.

https://doi.org/10.1182/blood.V128.22.2574.2574

Published: 2016

Journal Articles

Plasma Levels of IL-8 and Microparticle Tissue Factor Activity Are Associated with Mortality in Patients with Primary Influenza A/H1N1 Infection

Matthew T. Rondina, MD, Kohei Tatsumi, MD PhD, Julie A. Bastarache, MD, Nigel Mackman, PhD

Blood (2015) 126 (23): 3544.

https://doi.org/10.1182/blood.V126.23.3544.3544

Published: 2015

Journal Articles

Rebalanced Thrombin Generation in Liver Cirrhosis Calls for Tailored Transfusion Protocols

Romy Kremers, MSc, Marie-Claire Kleinegris, MD, Hugo ten Cate, MD PhD, Bas De Laat, MD PhD, Rob Wagenvoord, PhD, Coenraad Hemker, MD PhD

Blood (2015) 126 (23): 3523.

https://doi.org/10.1182/blood.V126.23.3523.3523

Published: 2015

Journal Articles

Identification of Persons with Acquired Hemophilia in a Large Electronic Health Record Database

Michael Wang, MD, Anissa Cyhaniuk, MS, David L Cooper, MD MBA, Neeraj N Iyer, PhD

Blood (2015) 126 (23): 3271.

https://doi.org/10.1182/blood.V126.23.3271.3271

Published: 2015

Journal Articles

In Vitro Assessment of Altered Thrombin-Fibrinogen Interaction As a Mechanism for Acute Traumatic Coagulopathy

Michael Adam Meledeo, PhD, Armando C Rodriguez, BS, Chet R Voelker, BS, James A Bynum, PhD, Andrew P Cap, MDPhD

Blood (2015) 126 (23): 1075.

https://doi.org/10.1182/blood.V126.23.1075.1075

Published: 2015

Journal Articles

Green neutrophilic inclusions could be a sign of impending death!

Tarek Jazaerly, Ali M. Gabali

Blood (2014) 123 (5): 614.

https://doi.org/10.1182/blood-2013-10-535856

Published: 2014

Journal Articles

Red Blood Cells Preserve Platelet Function and Coagulation From The Effects Of Acidemia

James E Campbell, PhD, Melanie V Valeciana, BS, Armando C Rodriguez, BS, James K Aden, PhD, Michael A Meledeo, PhD, Andrew P Cap, MD, PhD

Blood (2013) 122 (21): 4765.

https://doi.org/10.1182/blood.V122.21.4765.4765

Published: 2013

Journal Articles

Concomittant Acquired Von Willebrand Disease and Acquired Factor V Deficiency Causing a Severe Bleeding Diathesis Due To Multiple Myeloma With Amyloidosis

Nataliya Melnyk, MD, Jonathan Harrison, MD

Blood (2013) 122 (21): 4788.

https://doi.org/10.1182/blood.V122.21.4788.4788

Published: 2013

Journal Articles

Evaluation Of Laboratory and Clinical Markers For Predicting Survival In TTP/HUS: A Single Center Retrospective Study

Colin A Hardin, MD, Pallawi Torka, MBBS, Veera Durga Panuganty, MBBS, Mijung Lee, MD, Dongliang Wang, PhD, Ajeet Gajra, MD, MBBS

Blood (2013) 122 (21): 1082.

https://doi.org/10.1182/blood.V122.21.1082.1082

Published: 2013

Journal Articles

Isolated Prolonged Prothrombin Time Correlates with Serum Immunoglobulin Levels in Patients with Multiple Myeloma

Soumya Pandey, MD, Steven R Post, PhD, Daisy V. Alapat, MD, Ginell R. Post, MD, PhD

Blood (2011) 118 (21): 1225.

https://doi.org/10.1182/blood.V118.21.1225.1225

Published: 2011

Journal Articles

Anti-Inhibitor Coagulant Complex, Prothrombin Complex Concentrate, and Recombinant Factor VIIa Reverse Prothrombin Time Prolonged by Edoxaban In Human Plasma

Yoshiyuki Morishima, Ph.D., Yuko Honda, Toshiro Shibano, Ph.D.

Blood (2010) 116 (21): 3319.

https://doi.org/10.1182/blood.V116.21.3319.3319

Published: 2010

Journal Articles

Comparison of Laboratory Assays to Measure Rivaroxaban and Dabigatran

Severine Robert, François Mullier, Hassan Mekouar, Florence Polet, Jonathan Douxfils, Françoise Biot, Marie-Christine Lambert, Justine Baudar, Philippe Devel, Christian J. Chatelain, Bernard Chatelain, Jean-Michel Dogné

Blood (2010) 116 (21): 3332.

https://doi.org/10.1182/blood.V116.21.3332.3332

Published: 2010

Journal Articles

A Case of FVII Inhibitor.

Michael Joshua Levitt, MD, Arthur A. Topilow, MD, William Lerner, MD, Peter Mencel, MD, Carl Henningson, MD, David Benjamin Greenberg, MD, Claire S. Philipp, MD

Blood (2010) 116 (21): 3655.

https://doi.org/10.1182/blood.V116.21.3655.3655

Published: 2010

Journal Articles

Stomatocytosis Heralding a Case of Acute Wilsonian Crisis: Case Report and Review of the Literature.

Amit R. Mehta, MD, Gratian Salaru, MD, Jonathan Harrison, MD

Blood (2009) 114 (22): 5090.

https://doi.org/10.1182/blood.V114.22.5090.5090

Published: 2009

NARROW

Frozen Plasma Transfusion Practices in Ontario-an Electronic Audit at Five Tertiary Care Hospitals to Inform a Knowledge Translation Strategy to Reduce Inappropriate Plasma Transfusions

A Single-Institution Retrospective Study of Causes of Prolonged Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) in the Outpatient Setting

Dysfunction of Bone Marrow Endothelial Progenitor Cells from Subjects with Prolonged Isolated Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation Can be Improved By N-Acetyl-L-Cysteine

Prolonged Prothrombin Time in DIC: Contributions of Excess Thrombin and Fibrinogen Degradation Products

Preliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies

Identification and Characterization of a New Mutation in Coagulation Factor VII (Carmel mutation), with Different Reactivity Towards Tissue Factors of Different Origin

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

Plasma Levels of IL-8 and Microparticle Tissue Factor Activity Are Associated with Mortality in Patients with Primary Influenza A/H1N1 Infection

Rebalanced Thrombin Generation in Liver Cirrhosis Calls for Tailored Transfusion Protocols

Identification of Persons with Acquired Hemophilia in a Large Electronic Health Record Database

In Vitro Assessment of Altered Thrombin-Fibrinogen Interaction As a Mechanism for Acute Traumatic Coagulopathy

Green neutrophilic inclusions could be a sign of impending death!

Red Blood Cells Preserve Platelet Function and Coagulation From The Effects Of Acidemia

Concomittant Acquired Von Willebrand Disease and Acquired Factor V Deficiency Causing a Severe Bleeding Diathesis Due To Multiple Myeloma With Amyloidosis

Evaluation Of Laboratory and Clinical Markers For Predicting Survival In TTP/HUS: A Single Center Retrospective Study

Isolated Prolonged Prothrombin Time Correlates with Serum Immunoglobulin Levels in Patients with Multiple Myeloma

Anti-Inhibitor Coagulant Complex, Prothrombin Complex Concentrate, and Recombinant Factor VIIa Reverse Prothrombin Time Prolonged by Edoxaban In Human Plasma

Comparison of Laboratory Assays to Measure Rivaroxaban and Dabigatran

A Case of FVII Inhibitor.

Stomatocytosis Heralding a Case of Acute Wilsonian Crisis: Case Report and Review of the Literature.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only